Sampre Nutritions Faces Financial Struggles Amidst Revenue Growth and Market Decline

Sampre Nutritions, a microcap player in the FMCG sector, has recently experienced a financial trend adjustment reflecting challenges in its performance metrics. The company's net sales for the quarter ending March 2025 reached a notable Rs 7.77 crore, marking a high point in revenue generation. However, this positive aspect is overshadowed by significant declines in other key financial indicators.
The company's profit after tax (PAT) has plummeted to Rs -7.35 crore, a staggering drop compared to the previous four-quarter average. Additionally, the PBDIT stands at a low of Rs -6.27 crore, while the profit before tax, excluding other income, is recorded at Rs -7.52 crore. The earnings per share (EPS) also reflect a downturn, landing at Rs -3.50.

In terms of market performance, Sampre Nutritions has struggled against the broader market, with a year-to-date stock return of -60.85%, contrasting sharply with the Sensex's gain of 4.07% over the same period. Over the past year, the stock has declined by 53.12%, while the Sensex has risen by 9.33%. This stark comparison highlights the challenges faced by Sampre Nutritions in maintaining competitiveness within the FMCG industry.